Low concentration of BPC 157 such as 0.1 or 1 g/ml did not induce significant vasorelaxation
However, BPC-157 has never completed human clinical trials, so its safety profile in humans is unknown
Over the past couple of years, several reviews have been published in academic journals by researchers at major universities in the U.S., Britain, and Poland
If your goal is even tone or pigmentation, safer, evidence-based options exist
Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
A proud graduate of Barry University with a Masters in Family Medicine, Amparo blends medical expertise with an artistic eye to deliver safe, natural, and high-quality aesthetic care